Results 191 to 200 of about 16,485 (256)

Limited Clinical Efficacy with Potential Adverse Events in a Pilot Study of Autologous Adoptive Cell Therapy in Canine Oral Malignant Melanoma. [PDF]

Vet Sci
Xia YY, Chi KH, Liao AT, Lee JJ.
europepmc   +1 more source

A study of the relationship between circulating cytokines (interleukin-2 receptor and tumor necrosis factor receptor 2) and risk of B-cell non-hodgkin lymphoma. [PDF]

Ann Hematol
Abd El-Ghani SE, Abido HY, Tawfik NM, Shaheen G, Ellithy HN.   +4 more
europepmc   +1 more source

Generation of effector cells from T cell subsets [PDF]

, 1979
Koszinowski, Ulrich H., Simon, M. M.
core  

Recent advances in biomimetic nanodelivery systems for cancer Immunotherapy. [PDF]

Mater Today Bio
Yang J, Li X, Li T, Mei J, Chen Y.
europepmc   +1 more source

Reassessing granzyme B: unveiling perforin-independent versatility in immune responses and therapeutic potentials. [PDF]

Front Immunol
Thompson R, Cao X.
europepmc   +1 more source

Lifileucel: FDA-approved T-cell therapy for melanoma. [PDF]

Oncologist
Kwong MLM, Yang JC.
europepmc   +1 more source

The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC [PDF]

Biomolecules
Omero F, Speranza D, Murdaca G, Cavaleri M, Marafioti M, Cianci V, Berretta M, Casciaro M, Gangemi S, Santarpia M.   +9 more
europepmc   +1 more source

Advances in Liposomal Interleukin and Liposomal Interleukin Gene Therapy for Cancer: A Comprehensive Review of Preclinical Studies. [PDF]

Pharmaceutics
Kubbara EA, Bolad A, Malibary H.
europepmc   +1 more source

Protein kinase A and local signaling in cancer. [PDF]

Biochem J
Rosenthal KJ, Gordan JD, Scott JD.
europepmc   +1 more source

Global research trends of immunosenescence and immunotherapy: A bibliometric study. [PDF]

Hum Vaccin Immunother
Li W, Xiao L, Li H, Cui W.
europepmc   +1 more source